Gino Divittorio, MD
Rheumatology · Mobile, ALNPI 1366456295
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $90,800 of the $139,263 with a category attached, or 65.2%. AbbVie accounts for 68.8% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2019 at $71,725 and has fallen 98.9% since, to $812 in 2025. Among rheumatology clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 703 payments — averaging $198.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$96K
- Pfizer$37K
- Amgen$2K
- Johnson & Johnson$1K
- Novartis$1K
- UCB, Inc.$727
- plus $2K from 19 others
What the payments were for
- Consulting fees$13,63610%
- Speaking & faculty fees$90,80065%
- Travel & lodging$18,96914%
- Food & beverage$15,61711%
- Education$2410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 305 | $95,768 |
| Pfizer(2 entities) | 67 | $36,540 |
| Amgen(2 entities) | 82 | $1,591 |
| Johnson & Johnson | 56 | $1,169 |
| Novartis | 42 | $1,104 |
| UCB, Inc. | 35 | $727 |
| Boehringer Ingelheim | 30 | $575 |
| GSK | 22 | $539 |
| Radius Health, Inc. | 9 | $171 |
| Lilly USA, LLC | 9 | $168 |
| AstraZeneca(2 entities) | 8 | $143 |
| Aurinia Pharma U.S., Inc. | 7 | $132 |
| E.r. Squibb & Sons, L.L.C. | 7 | $129 |
| Bristol Myers Squibb | 5 | $97 |
| Octapharma USA, Inc. | 3 | $70 |
| Sanofi-aventis U.S. LLC | 1 | $67 |
| Organon | 3 | $59 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $44 |
| Sandoz | 2 | $35 |
| Genentech USA, Inc. | 2 | $31 |
| Sobi, Inc | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$139,263 in reported general payments places this provider in the 90th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RinvoqUpadacitinib | 18 | $111,890 |
| Humira(Cf) PenAdalimumab | 13 | $88,741 |
| Xeljanz XrTofacitinib Citrate | 13 | $75,812 |
| Hydroxychloroquine Sulfate | 180 | $11,393 |
| MethotrexateMethotrexate Sodium | 123 | $3,691 |
| Celecoxib | 129 | $3,536 |
| Leflunomide | 70 | $2,903 |
| Duloxetine Hcl | 134 | $2,569 |
| Tramadol Hcl | 208 | $1,951 |
| Memantine Hcl | 81 | $1,873 |
| Pregabalin | 105 | $1,826 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 30 | $1,480 |
| Memantine Hcl ErMemantine Hcl | 19 | $1,359 |
| Tramadol Hcl ErTramadol Hcl | 12 | $1,216 |
| Febuxostat | 18 | $1,038 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq | $95,768 | $111,89018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 rheumatology providers in Alabama.
Other rheumatology in Mobile
- Thomas McGeeMobile$12K
- Teresa OglesbyMobile$11K
- Yanming XingMobile$11K
- James LawrenceMobile$10K
- Sonia SavaniMobile$10K
- Thomas MyersMobile$9K
- Hamdy AhmedMobile$5K
- Daren ScroggieMobile$4K
- Anthony TurkiewiczMountain Brk$2.2M
- Jeffrey CurtisBirmingham$612K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.